Related Experiment Video
Updated: Jun 28, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Posaconazole mono- or combination therapy for treatment of murine zygomycosis
Ashraf S Ibrahim1, Teclegiorgis Gebremariam, Julie A Schwartz
1Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles Medical Center, Torrance, 90502, USA. ibrahim@labiomed.org
Abstract:
We compared the efficacy of combination posaconazole-liposomal amphotericin B (LAmB) therapy to monotherapy with either drug in diabetic ketoacidotic or neutropenic mice with disseminated zygomycosis caused by Rhizopus oryzae. Combination therapy was no better than LAmB alone, and posaconazole monotherapy did not improve survival or reduce fungal burden versus placebo.
Related Concept Videos
Antifungal Agents
Fungal Group Zygomycota
Antiprotozoal Agents
Cryptococcal Meningitis
Candidiasis
Anthelminthic Agents
